Kymera Therapeutics (KYMR) Other Gross PP&E Adjustments: 2019-2025
Historic Other Gross PP&E Adjustments for Kymera Therapeutics (KYMR) over the last 5 years, with Sep 2025 value amounting to $22.4 million.
- Kymera Therapeutics' Other Gross PP&E Adjustments rose 61.31% to $22.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.3 million, marking a year-over-year increase of 113.39%. This contributed to the annual value of $16.4 million for FY2024, which is 826.25% up from last year.
- According to the latest figures from Q3 2025, Kymera Therapeutics' Other Gross PP&E Adjustments is $22.4 million, which was up 16.08% from $19.3 million recorded in Q2 2025.
- Kymera Therapeutics' 5-year Other Gross PP&E Adjustments high stood at $22.4 million for Q3 2025, and its period low was -$33.7 million during Q1 2023.
- Over the past 3 years, Kymera Therapeutics' median Other Gross PP&E Adjustments value was $11.3 million (recorded in 2024), while the average stood at $3.7 million.
- Per our database at Business Quant, Kymera Therapeutics' Other Gross PP&E Adjustments crashed by 763.15% in 2023 and then spiked by 826.25% in 2024.
- Kymera Therapeutics' Other Gross PP&E Adjustments (Quarterly) stood at $5.0 million in 2021, then surged by 88.68% to $9.3 million in 2022, then tumbled by 81.01% to $1.8 million in 2023, then spiked by 826.25% to $16.4 million in 2024, then spiked by 61.31% to $22.4 million in 2025.
- Its Other Gross PP&E Adjustments stands at $22.4 million for Q3 2025, versus $19.3 million for Q2 2025 and $17.0 million for Q1 2025.